| Paralogue | Variant | Associated Disease | Mapping Quality | Consensus | Pubmed |
|---|---|---|---|---|---|
| SCN1A | D1727G | Myoclonic epilepsy of infancy | High | 9 | 23195492 |
To assess whether the paralogue annotation here confidently predicts that variation at this residue is pathogenic, it is important to check the reports in the Pubmed links above to ascertain that the mutations in these paralogues have been proved likely to be disease-causing. It is also important to check that the direction of effect of the variant in the paralogue is compatible with your observed phenotype in SCN5A.
| SCN5A | ----IDDMFNFQTFANSMLCLFQITTSAGW>D<GLLSPILNTGPPYCDPTLPN-S-NGSRGD- | 1741 |
| SCN1A | ----IDDMFNFETFGNSMICLFQITTSAGW>D<GLLAPILNSKPPDCDPNKVN-PGSSVKGD- | 1755 |
| SCN2A | ----IDDMFNFETFGNSMICLFQITTSAGW>D<GLLAPILNSGPPDCDPDKDH-PGSSVKGD- | 1745 |
| SCN3A | ----IDDMFNFETFGNSMICLFQITTSAGW>D<GLLAPILNSAPPDCDPDTIH-PGSSVKGD- | 1740 |
| SCN4A | ----IDDMFNFETFGNSIICLFEITTSAGW>D<GLLNPILNSGPPDCDPNLEN-PGTSVKGD- | 1567 |
| SCN7A | ----INDVSNFETFGNSMLCLFQVAIFAGW>D<GMLDAIFNSKWSDCDPDKIN-PGTQVRGD- | 1465 |
| SCN8A | ----IDDMFNFETFGNSMICLFQITTSAGW>D<GLLLPILN-RPPDCSLDKEH-PGSGFKGD- | 1735 |
| SCN9A | ----INDMFNFETFGNSMICLFQITTSAGW>D<GLLAPILNSKPPDCDPKKVH-PGSSVEGD- | 1718 |
| SCN10A | ----IDDMFNFQTFANSMLCLFQITTSAGW>D<GLLSPILNTGPPYCDPNLPN-S-NGTRGD- | 1691 |
| SCN11A | ----IDDIFNFKTFASSMLCLFQISTSAGW>D<SLLSPMLRSKES-CN---------SSSEN- | 1573 |
| CACNA1A | DEFQITEHNNFRTFFQALMLLFRSATGEAW>H<NIMLSCLSG--KPCDKNSGIL-----T-R- | 1780 |
| CACNA1B | ----INRHNNFRTFLQALMLLFRSATGEAW>H<EIMLSCLSN--QACDE---Q------A-NA | 1677 |
| CACNA1C | ----INRNNNFQTFPQAVLLLFRCATGEAW>Q<DIMLACMPG--KKCAPESEP-SNSTEGETP | 1446 |
| CACNA1D | ----INRNNNFQTFPQAVLLLFRCATGEAW>Q<EIMLACLPG--KLCDPESDY--NPGE-EYT | 1454 |
| CACNA1E | ----INRHNNFRSFFGSLMLLFRSATGEAW>Q<EIMLSCLGE--KGCEPDTTAPSGQNEN-E- | 1692 |
| CACNA1F | ----INRNNNFQTFPQAVLLLFRCATGEAW>Q<EIMLASLPG--NRCDPESDF--GPGE-EFT | 1411 |
| CACNA1G | -CEGLGRHATFRNFGMAFLTLFRVSTGDNW>N<GIMKDTLRD----CDQEST-----C----- | 1821 |
| CACNA1H | -CEGLSRHATFSNFGMAFLTLFRVSTGDNW>N<GIMKDTLRE----CSREDKH----C---LS | 1830 |
| CACNA1I | -CEGMSRHATFENFGMAFLTLFQVSTGDNW>N<GIMKDTLRD----CTHDERS----C---LS | 1700 |
| CACNA1S | ----INRNNNFQTFPQAVLLLFRCATGEAW>Q<EILLACSYG--KLCDPESDY--APGE-EYT | 1351 |
| cons | > < |
| Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
|---|---|---|---|---|---|
| p.D1714G | c.5141A>G | Inherited Arrhythmia | BrS | rs199473628 | SIFT: deleterious Polyphen: probably damaging |
| Reports | Inherited Arrhythmia | BrS | Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties. Acta Physiol Scand. 2005 185(4):291-301. 16266370 | ||
| Inherited Arrhythmia | BrS | Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm. 2009 6(3):341-8. 19251209 | |||
| Inherited Arrhythmia | BrS | An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm. 2010 7(1):33-46. 20129283 | |||
| p.Asp1714Asn | c.5140G>A | Unknown | SIFT: Polyphen: | ||